The Cell & Gene Therapy Innovation Summit will be held from February 6 - 7, 2019 in Berlin, Germany.

David Sourdive, Co-Founder and Executive Vice President Technical Operations at Cellectis will be presenting on the "First lessions learned from bringing allogeneic adoptive T-cell immunotherapies to the clinic" on Wednesday, February 6 from 11:00 AM to 11:30 AM CET.